FDA approves devices, drugs and dosing regimens

In August, the FDA approved devices, drugs and dosing regimens to treat a range of ocular indications, including glaucoma, dry eye, age-related macular degeneration, postoperative pain and inflammation, and neurotrophic keratitis.
FDA approves Inveltys for treatment of inflammation, pain after ocular surgery
The FDA has approved Inveltys, a twice-daily ocular corticosteroid, for the treatment of postoperative inflammation and pain after ocular surgery according to Kala Pharmaceuticals. Read more.
FDA approves Oxervate, the first drug to treat neurotrophic keratitis
The FDA has

Full Story →